Acadia Pharmaceuticals (ACAD) Exchange Rate Effect (2010 - 2026)
Acadia Pharmaceuticals' (ACAD) quarterly Exchange Rate Effect came in at $25000.0 in Q1 2026, up 600.0% year-on-year from $3571.4 in Q1 2025, and up 257.14% quarter-over-quarter from $7000.0 in Q4 2025.
Acadia Pharmaceuticals (ACAD) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Acadia Pharmaceuticals' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $25000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 600.0% year-over-year to $25000.0 in Q1 2026; TTM through Mar 2026 was $56000.0, a 153.85% increase from a year earlier, with the FY2025 full-year figure at $26000.0, up 127.66% from the prior year.
- Exchange Rate Effect advanced to $25000.0 in Q1 2026 per ACAD's latest filing, from $7000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $25000.0 in Q1 2026 and bottomed at -$60000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is $2000.0 (2022), against an average of -$3666.7.
- Across the five-year window, Exchange Rate Effect plunged 950.0% in 2024 and soared 700.0% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$8000.0 in 2022, then sank by 50.0% to -$12000.0 in 2023, then tumbled by 400.0% to -$60000.0 in 2024, then surged by 111.67% to $7000.0 in 2025, then jumped by 257.14% to $25000.0 in 2026.
- Per Business Quant, the three latest ACAD Exchange Rate Effect figures stand at $25000.0 (Q1 2026), $7000.0 (Q4 2025), and $24000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn | 25,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25,000.00 |
| Mar 31, 2026 | 25,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Dec 31, 2024 | -60,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Sep 30, 2024 | -42,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Dec 31, 2023 | -12,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Sep 30, 2023 | -4,000.00 |